![Immunome](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2020/08/Immunome.jpg?resize=735%2C400&ssl=1)
Immunome Merges with Morphimmune, Secures $125M in Funding for Accelerated Cancer Therapy Development
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced its third-quarter financial results ending September 30, 2023, and provided a corporate update that includes the completion of a significant merger …
Immunome Merges with Morphimmune, Secures $125M in Funding for Accelerated Cancer Therapy Development Read More